What is Mantra Bio?
Mantra Bio is a company operating within the biotechnology sector, focusing on developing innovative solutions. The recent major enterprise-level funding suggests a company poised for significant scaling and market expansion. The strategic investment indicates a strong belief from backers in Mantra Bio's long-term vision and technological advancements.
How much funding has Mantra Bio raised?
Mantra Bio has raised a total of $25M across 1 funding round:
Series A
$25M
Series A (2020): $25M with participation from The 8VC, Allen & Company, Viking Global Investors, and Box Group
Key Investors in Mantra Bio
The 8VC
8VC is a venture capital firm known for investing in early-stage technology companies, often with a focus on disruptive innovation and deep technology.
Allen & Company
Allen & Company is a long-standing investment firm specializing in financial planning and wealth management, with a broad scope that may extend to strategic corporate investments.
Viking Global Investors
Viking Global Investors is a global investment firm that employs a research-intensive approach, focusing on long-term equity investments across various industries.
What's next for Mantra Bio?
With this substantial backing, Mantra Bio is expected to accelerate its research and development initiatives, potentially expanding its product pipeline and market reach. The strategic nature of the recent investment suggests a focus on synergistic growth, possibly involving partnerships or acquisitions that align with the company's core objectives. This financing round positions Mantra Bio for a critical phase of growth and market penetration.
See full Mantra Bio company page
